LARGO, Fla., Aug. 3 /PRNewswire-FirstCall/ -- GeoPharma, Inc. stated today that it will announce its earnings for the three months ended June 30, 2006 and will host a conference call on Thursday, August 10, 2006. The Company’s conference call will be held at 11:30 a.m. (ET) on Thursday, August 10, 2006 with CEO Mihir Taneja and VP/CFO Carol Dore-Falcone. A separate release will follow with the conference call dial in number and related participant passcodes.
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company’s growth strategy is to capitalize on its manufacturing expertise to develop high margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma’s competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at http://www.geopharmainc.com, http://www.onlineihp.com and http://www.carbslim.com .
This press release may contain statements, which constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries’ expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company’s management as of the date hereof, and actual results may vary based upon future events, both within and without management’s control. Important factors that could cause such differences are described in the company’s periodic filings with the Securities and Exchange Commission.
Contact Information: GeoPharma: Carol Dore-Falcone, VP/CFO Tel: 727-544-8866 x244 E: cdf@onlineihp.com
GeoPharma, Inc.
CONTACT: Carol Dore-Falcone, VP and CFO, GeoPharma, +1-727-544-8866, ext.244, or cdf@onlineihp.com
